Literature DB >> 8851897

Diurnal variations of serum erythropoietin at sea level and altitude.

T Klausen1, T D Poulsen, N Fogh-Andersen, J P Richalet, O J Nielsen, N V Olsen.   

Abstract

This study tested the hypothesis that the diurnal variations of serum-erythropoietin concentration (serum-EPO) observed in normoxia also exist in hypoxia. The study also attempted to investigate the regulation of EPO production during sustained hypoxia. Nine subjects were investigated at sea level and during 4 days at an altitude of 4350 m. Median sea level serum-EPO concentration was 6 (range 6-13) U.l-1. Serum-EPO concentration increased after 18 and 42 h at altitude, [58 (range 39-240) and 54 (range 36-340) U.l-1, respectively], and then decreased after 64 and 88 h at altitude [34 (range 18-290) and 31 (range 17-104) U.l-1, respectively]. These changes of serum-EPO concentration were correlated to the changes in arterial blood oxygen saturation (r = -0.60, P = 0.0009), pH (r = 0.67, P = 0.003), and in-vivo venous blood oxygen half saturation tension (r = -0.68, P = 0.004) but not to the changes in 2, 3 diphosphoglycerate. After 64 h at altitude, six of the nine subjects had down-regulated their serum-EPO concentrations so that median values were three times above those at sea level. These six subjects had significant diurnal variations of serum-EPO concentration at sea level; the nadir occurred between 0800-1600 hours [6 (range 4-13) U.l-1], and peak concentrations occurred at 0400 hours [9 (range 8-14) U.l-1, P = 0.02]. After 64 h at altitude, the subjects had significant diurnal variations of serum-EPO concentration; the nadir occurred at 1600 hours [20 (range 16-26) U.l-1], and peak concentrations occurred at 0400 hours [31 (range 20-38) U.l-1, P = 0.02]. This study demonstrated diurnal variations of serum-EPO concentration in normoxia and hypoxia, with comparable time courses of median values. The results also suggested that EPO production at altitude is influenced by changes in pH and haemoglobin oxygen affinity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8851897     DOI: 10.1007/bf00599688

Source DB:  PubMed          Journal:  Eur J Appl Physiol Occup Physiol        ISSN: 0301-5548


  16 in total

1.  Arterial oxygen status determined with routine pH/blood gas equipment and multi-wavelength hemoximetry: reference values, precision, and accuracy.

Authors:  O Siggaard-Andersen; P D Wimberley; N Fogh-Andersen; I H Gøthgen
Journal:  Scand J Clin Lab Invest Suppl       Date:  1990

Review 2.  Erythropoietin: structure, control of production, and function.

Authors:  W Jelkmann
Journal:  Physiol Rev       Date:  1992-04       Impact factor: 37.312

3.  Diurnal variations of acute mountain sickness, colour vision, and plasma cortisol and ACTH at high altitude.

Authors:  J P Richalet; V Rutgers; P Bouchet; J C Rymer; A Kéromès; G Duval-Arnould; C Rathat
Journal:  Aviat Space Environ Med       Date:  1989-02

4.  Triggering of erythropoietin production by hypoxia is inhibited by respiratory and metabolic acidosis.

Authors:  K U Eckardt; A Kurtz; C Bauer
Journal:  Am J Physiol       Date:  1990-03

5.  Plasma erythropoietin in men and mice during acclimatization to different altitudes.

Authors:  P H Abbrecht; J K Littell
Journal:  J Appl Physiol       Date:  1972-01       Impact factor: 3.531

6.  Diurnal variations in serum erythropoietin levels in healthy subjects and sleep apnea patients.

Authors:  C Cahan; M J Decker; J L Arnold; L H Washington; J D Veldhuis; E Goldwasser; K P Strohl
Journal:  J Appl Physiol (1985)       Date:  1992-06

Review 7.  Serum immunoreactive erythropoietin in health and disease.

Authors:  J L Spivak
Journal:  Int J Cell Cloning       Date:  1990-01

Review 8.  Red blood cell function in hypoxia at altitude and exercise.

Authors:  H Mairbäurl
Journal:  Int J Sports Med       Date:  1994-02       Impact factor: 3.118

9.  Diurnal variations of serum erythropoietin in trained and untrained subjects.

Authors:  T Klausen; F Dela; E Hippe; H Galbo
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1993

10.  Regulatory mechanism of erythropoietin production: effects of hypoxemia and hypercarbia.

Authors:  R A Cohen; M E Miller; J F Garcia; G Moccia; E P Cronkite
Journal:  Exp Hematol       Date:  1981-05       Impact factor: 3.084

View more
  15 in total

1.  Determining an erythropoietin threshold is not sufficient for accelerating erythrocyte production by Julien V. Brugniaux, Aurélien Pichon.

Authors:  Gustave Savourey; Pietro E di Prampero
Journal:  Eur J Appl Physiol       Date:  2006-12-13       Impact factor: 3.078

2.  Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease.

Authors:  Edouard R Martin; Mark T Smith; Bradley J Maroni; Qing C Zuraw; Emil M deGoma
Journal:  Am J Nephrol       Date:  2017-03-25       Impact factor: 3.754

Review 3.  Anaemia and iron deficiency in athletes. Practical recommendations for treatment.

Authors:  J C Chatard; I Mujika; C Guy; J R Lacour
Journal:  Sports Med       Date:  1999-04       Impact factor: 11.136

Review 4.  Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid.

Authors:  Randall L Wilber
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

5.  Circadian rhythm of granulocyte-macrophage colony-stimulating factor in normal subjects and neutropenic hospitalised patients.

Authors:  M A Abdelaal; I A Hashim; T H Zawawi; S K Felimban; E M Sobhi; O Jeje; G A Oni
Journal:  Ir J Med Sci       Date:  2000 Jan-Mar       Impact factor: 1.568

6.  Human erythropoietin response to hypocapnic hypoxia, normocapnic hypoxia, and hypocapnic normoxia.

Authors:  T Klausen; H Christensen; J M Hansen; O J Nielsen; N Fogh-Andersen; N V Olsen
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

7.  Regulation of clock-controlled genes in mammals.

Authors:  Katarzyna Bozek; Angela Relógio; Szymon M Kielbasa; Markus Heine; Christof Dame; Achim Kramer; Hanspeter Herzel
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

8.  Increased erythropoietin concentration after repeated apneas in humans.

Authors:  Robert de Bruijn; Matt Richardson; Erika Schagatay
Journal:  Eur J Appl Physiol       Date:  2007-12-19       Impact factor: 3.078

9.  Diurnal changes of arterial oxygen saturation and erythropoietin concentration in male and female highlanders.

Authors:  Edgar Cristancho; Alain Riveros; Armando Sánchez; Oscar Peñuela; Dieter Böning
Journal:  Physiol Rep       Date:  2016-09

10.  Plasma soluble erythropoietin receptor is decreased during sleep in Andean highlanders with Chronic Mountain Sickness.

Authors:  Francisco C Villafuerte; Noemí Corante; Cecilia Anza-Ramírez; Rómulo Figueroa-Mujíca; Gustavo Vizcardo-Galindo; Andy Mercado; José Luis Macarlupú; Fabiola León-Velarde
Journal:  J Appl Physiol (1985)       Date:  2016-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.